We serve Chemical Name:5-pyridin-2-ylthiophene-2-sulfonohydrazide CAS:175202-74-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:5-pyridin-2-ylthiophene-2-sulfonohydrazide
CAS.NO:175202-74-1
Synonyms:5-(pyridin-2-yl)thiophene-2-sulfonohydrazide;HMS555C05
Molecular Formula:C9H9N3O2S2
Molecular Weight:255.31700
HS Code:2935009090
Physical and Chemical Properties:
Melting point:109ºC
Boiling point:484.6ºC at 760mmHg
Density:1.457g/cm3
Index of Refraction:1.644
PSA:121.70000
Exact Mass:255.01400
LogP:3.13410
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 5-(pyridin-2-yl)thiophene-2-sulfonohydrazide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,HMS555C05 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-(pyridin-2-yl)thiophene-2-sulfonohydrazide Use and application,5-(pyridin-2-yl)thiophene-2-sulfonohydrazide technical grade,usp/ep/jp grade.
Related News: Atom utilization is also better with biocatalysis; where two or more moieties on the same molecule have the capacity to undergo a particular reaction, biocatalytic processing guarantees that one site is consistently chosen over the other. N4,O3′-bis-(2-ethyl-butyryl)-2′-deoxy-[5′]cytidylic acid manufacturers Grégoire brings more than 20 years of technological innovation, strategy and digital entrepreneurship experience to the team. He started his career as the founder and CEO of Andrexen, an innovative Unified Communication Cloud Platform. 7-hydroxy-3,6,6-trimethyl-4-oxocyclohept-2-en-1-yl (E)-3-(4-nitrophenyl)acrylate suppliers A new post-hoc analysis of pooled data from the TULIP phase III clinical trials being presented at the annual European Congress of Rheumatology (EULAR 2021) showed anifrolumab was consistently associated with improvements in both skin rash and arthritis across three different disease measures each, compared to placebo, in patients with moderate to severe systemic lupus erythematosus (SLE). 4-pentoxy-N-phenylaniline vendor & factory.
